Malkani Dhiraj H
SEC insider (Form 3/4/5 filer). CIK 0002143491. CHIEF STRATEGY OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA). 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in LONDON.
Companies Malkani Dhiraj H has filed insider reports for
- Kiniksa Pharmaceuticals International, plc (KNSA): Officer, CHIEF STRATEGY OFFICER
Malkani Dhiraj H
CIK: 0002143491
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Kiniksa Pharmaceuticals International, plc
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectShare Option
82.6K shares- - Jul 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectRestricted Share Unit
14K shares- - Jul 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectPerformance Share Option
2.1K shares- - Jul 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectPerformance Share Option
2.2K shares- - Jul 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectPerformance Share Unit
1.2K shares- - Jul 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectPerformance Share Unit
1.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Share Option | 82,600 | - | - | Direct |
| Jul 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Restricted Share Unit | 14,000 | - | - | Direct |
| Jul 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Performance Share Option | 2,119 | - | - | Direct |
| Jul 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Performance Share Option | 2,188 | - | - | Direct |
| Jul 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Performance Share Unit | 1,245 | - | - | Direct |
| Jul 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Performance Share Unit | 1,307 | - | - | Direct |
1-6 of 6 transactions